A multicenter observational study investigating the pathophysiology of ischemic atherosclerotic stroke (IAS) has identified significant sex-based disparities in clinical manifestations, systemic immune-inflammatory profiles, and prognostic risk factors. The research, which analyzed a cohort of 407 patients, highlights that biological sex serves as a critical variable influencing infarct topography and inflammatory responses, potentially necessitating more tailored clinical management and secondary prevention strategies. Researchers recorded baseline demographics, medical history, infarct locations, and immune-inflammatory biomarkers, and evaluated functional recovery during the subacute phase.
In the study cohort, men exhibited a higher proportion of IAS, accounting for 67.6% compared to 32.4% for women. Men exhibited significantly elevated levels of systemic inflammatory markers, including monocyte, erythrocyte, and leukocyte counts, as well as a higher systemic inflammatory response index (SIRI), with statistical significance reported at p = 0.001.
In contrast, female patients demonstrated a different profile characterized by distinct hematological parameters and anatomical stroke patterns. Women experienced higher relative platelet counts (p = 0.001) and a higher platelet-to-lymphocyte ratio (PLR, p = 0.017) compared to their male counterparts. Furthermore, the topography of the infarctions showed divergent patterns between the sexes. Female patients were more likely to present with right brainstem infarctions (p = 0.028) and bilateral cerebral infarctions (p = 0.036).
Regarding functional recovery, the study evaluated patients using the modified Rankin Scale (mRS) during the subacute phase. Findings indicated that women experienced modestly poorer functional recovery, as evidenced by higher mRS scores (p = 0.040).
Prognostic risk factors also emerged as highly sex-specific in the multivariable regression models utilized by the research team. In male patients, higher systemic inflammatory response index scores were independently associated with poorer functional outcomes (p = 0.031). Additionally, the 1-year incidence of major adverse cardiovascular and cerebrovascular events (MACCE) in men was found to be positively associated with higher mRS scores (OR = 1.70, p = 0.016). Conversely, an inverse relationship was observed between left-sided infarction and the incidence of 1-year MACCE in men (OR = 0.28, p = 0.017), suggesting that the location of the lesion within the vascular network carries specific prognostic implications for male patients.
For women, the identified prognostic factors included the platelet-to-lymphocyte ratio, which was linked to poorer functional outcomes (p = 0.049). Furthermore, smoking was identified as a significant risk factor for 1-year MACCE incidence in women (p = 0.009). The research team emphasized that while these associations provide important insights, the finding regarding smoking in women requires further validation in larger cohorts, primarily due to the limited number of female smokers included in the present study. This caution highlights the exploratory nature of the study and the necessity for more robust data sets to confirm these specific prognostic markers in a broader population.
The study underscores the complexity of ischemic atherosclerotic stroke, demonstrating that it is not a monolithic condition but rather a disease process modulated significantly by the biological sex of the patient. The distinct anatomical, immunological, and clinical profiles identified point toward the potential for sex-driven pathophysiological disparities that current stroke management protocols may not fully address.
While this observational research provides a foundation for understanding sex-based differences in IAS, the investigators acknowledge that the findings remain exploratory. Future studies with larger, more diverse patient cohorts are required to confirm these observations and to refine the regression models used to predict MACCE and functional recovery. Recognizing these pathophysiological variations is a vital step toward developing targeted follow-up strategies that address the unique needs of men and women, ultimately aiming to enhance secondary prevention and clinical outcomes for all patients surviving an ischemic atherosclerotic stroke.
Subject of Research: Sex-based disparities in ischemic atherosclerotic stroke pathophysiology
Article Title: Sex differences in clinical manifestations, functional outcome, and prognostic risk factors in ischemic atherosclerotic stroke: a multicenter observational study
Article References: Chen, D., Chen, Y., Liu, Y., Huang, Y., Du, W., Ye, L., Liao, H., Liang, R., Lu, Q., Wang, L., Wei, D., & Sun, J. (2026). Sex differences in clinical manifestations, functional outcome, and prognostic risk factors in ischemic atherosclerotic stroke: a multicenter observational study. Biology of Sex Differences. https://doi.org/10.1186/s13293-026-01021-5
Image Credits: AI Generated
DOI: 10.1186/s13293-026-01021-5
Keywords: Ischemic stroke, atherosclerotic stroke, sex differences, systemic inflammation, infarct topography, systemic inflammatory response index, platelet-to-lymphocyte ratio, functional recovery, stroke prognosis, cardiovascular events, cerebrovascular events, inflammatory biomarkers, stroke pathology, clinical management, secondary prevention
News Source: Cassandra Pierce. (November 17, 2026). Sex-Specific Differences Observed in Ischemic Stroke Outcomes and Inflammatory Profiles. Scienmag.



